Latest Transformation News

FlexiRoam Limited has reported its strongest quarterly operating cash flow ever, signalling a successful business reset and setting the stage for growth with a new AI-assisted connectivity platform.

Breakthrough Minerals Limited has voluntarily suspended trading on the ASX as it prepares to announce a significant mineral project acquisition and capital raising. The suspension is set to last until the announcement or the resumption of trading on 30 October 2025.

AdNeo Limited reports a robust 54% increase in customer receipts for Q1 FY26, driven by the strategic acquisition of Learnt Group and significant cost synergies. The company also slashes debt and advances its sales pipeline, positioning itself for cash flow positivity within the year.

Nelson Resources confirms high-grade gold assay results at its Yarri Project and partners with MEGA Resources to fully fund and manage development operations.

ActivEX Limited reports progress on multiple Queensland mineral projects, including a major drilling campaign at Gilberton and advancing rare earth exploration, while managing its portfolio through asset sales and loan facility extensions.

Atomo Diagnostics reported strong commercial momentum in Q1 FY26, highlighted by a key FDA submission for its FebriDx test and a successful capital raise of $1.3 million. The company also showcased promising clinical data for its Active Syphilis test and expanded its HIV Self-Test distribution channels.

Arafura Rare Earths has successfully raised A$475 million through a two-tranche institutional placement, backed by major investors including Hancock Prospecting, to fund the development of its Nolans Project.

Whitebark Energy’s fresh petrophysical analysis reveals significant dry gas zones in its Warro Gas Field, boosting its commercial prospects and prompting a $750,000 capital raise to fast-track development.

Neurizon Therapeutics has secured FDA clearance to resume clinical trials for its lead ALS drug NUZ-001, alongside a $5.2 million capital raise and a key licensing deal with Elanco Animal Health. These developments position the company for a critical growth phase in neurodegenerative disease therapeutics.

1414 Degrees has completed key milestones on its SiBox technology, advanced SiBrick storage media towards mass production, and acquired an exclusive licence for innovative silicon nanoparticle tech, backed by a $1.214 million capital raise.

Mont Royal Resources has completed a transformative merger with Commerce Resources, securing A$10 million to advance the Ashram Rare Earths Project, positioning itself as a key player in North America’s critical minerals sector.

Data # 3 Limited showcased strong FY25 financial results with record $3 billion gross sales and announced key board changes at its 2025 AGM. The company projects steady growth for FY26 despite some short-term challenges.